Skip to Main Content

Moderna, Inc. Common Stock

MRNA Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
MRNA Income Statement
MRNA Balance Sheet
MRNA Cash Flow
MRNA Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
MRNA Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
MRNA Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by MRNA's directors and management

Government lobbying spending instances

  • $10,000 Oct 18, 2024 Issue: Health Issues
  • $80,000 Sep 18, 2024 Issue: Foreign Relations Health Issues
  • $50,000 Jul 22, 2024 Issue: Medicare/Medicaid Health Issues
  • $45,000 Jul 22, 2024 Issue: Health Issues
  • $80,000 Jul 16, 2024 Issue: Foreign Relations Health Issues
  • $30,000 Jul 15, 2024 Issue: Taxation/Internal Revenue Code
  • $40,000 Apr 17, 2024 Issue: Medicare/Medicaid
  • $50,000 Jan 22, 2024 Issue: Medicare/Medicaid Health Issues
  • $45,000 Jan 22, 2024 Issue: Health Issues
  • $30,000 Jan 11, 2024 Issue: Taxation/Internal Revenue Code
  • $45,000 Oct 20, 2023 Issue: Health Issues
  • $50,000 Oct 20, 2023 Issue: Medicare/Medicaid Health Issues
  • $45,000 Jul 20, 2023 Issue: Health Issues
  • $80,000 Jul 19, 2023 Issue: Foreign Relations Health Issues
  • $50,000 Jul 19, 2023 Issue: Medicare/Medicaid Health Issues
  • $80,000 Jan 20, 2023 Issue: Foreign Relations Health Issues
  • $50,000 Jan 20, 2023 Issue: Health Issues
  • $45,000 Jan 20, 2023 Issue: Health Issues
  • $45,000 Oct 20, 2022 Issue: Health Issues
  • $50,000 Oct 20, 2022 Issue: Health Issues
  • $70,000 Oct 19, 2022 Issue: Foreign Relations Health Issues
  • $50,000 Jul 20, 2022 Issue: Health Issues
  • $45,000 Jul 20, 2022 Issue: Health Issues
  • $80,000 Jul 18, 2022 Issue: Foreign Relations Health Issues
  • $50,000 Apr 20, 2022 Issue: Health Issues
  • $80,000 Apr 20, 2022 Issue: Foreign Relations Health Issues
  • $45,000 Apr 20, 2022 Issue: Health Issues
  • $30,000 Jan 20, 2022 Issue: Health Issues
  • $50,000 Jan 19, 2022 Issue: Foreign Relations Health Issues
  • $50,000 Jan 19, 2022 Issue: Health Issues
  • $50,000 Oct 20, 2021 Issue: Health Issues
  • $30,000 Oct 20, 2021 Issue: Health Issues
  • $50,000 Oct 19, 2021 Issue: Foreign Relations Health Issues
  • $50,000 Jul 20, 2021 Issue: Health Issues
  • $30,000 Jul 20, 2021 Issue: Health Issues
  • $50,000 Jul 19, 2021 Issue: Pharmacy Foreign Relations Health Issues
  • $30,000 Apr 20, 2021 Issue: Health Issues
  • $50,000 Apr 20, 2021 Issue: Health Issues
  • $30,000 Apr 20, 2021 Issue: Health Issues
  • $50,000 Apr 20, 2021 Issue: Pharmacy Health Issues
  • $50,000 Jan 21, 2021 Issue: Health Issues
  • $50,000 Jan 20, 2021 Issue: Health Issues
  • $50,000 Oct 20, 2020 Issue: Health Issues
  • $50,000 Oct 20, 2020 Issue: Health Issues
  • $50,000 Jul 20, 2020 Issue: Health Issues
  • $20,000 Jul 20, 2020 Issue: Health Issues
  • $10,000 Apr 20, 2020 Issue: Health Issues
  • $30,000 Oct 21, 2019 Issue: Health Issues
  • $10,000 Jul 22, 2019 Issue: Health Issues

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of MRNA in WallStreetBets Daily Discussion

MRNA News

Recent insights relating to MRNA

CNBC Recommendations

Recent picks made for MRNA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MRNA

MRNA Top Shareholders
Shareholder
Shares Held
MRNA Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MRNA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view MRNA Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top